2569 patienter, som fik konventionel behandling for hjertesvigt, randomiseredes til at modtage enten placebo (n=1284) eller enalapril (n=1285).
2569 patients receiving conventional treatment for heart failure were randomly assigned to receive either placebo (n=1284) or enalapril (n=1285).